Nageshwar Budha

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Monoclonal Antibody

Lymph Node Metastasis

Top Venues

Clinical and translational science

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Gerald R Galluppi, Malidi Ahamadi, Souvik Bhattacharya, Nageshwar Budha, Ferdous Gheyas, Chi-Chung Li, Yuan Chen, Anne-Gaëlle Dosne, Niels Rode Kristensen, Mindy Magee, Mahesh N Samtani, Vikram Sinha, Kunal S Taskar, Vijay V Upreti, Jianning Yang, Jack Cook
Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program. Clinical pharmacology and therapeutics 116 (2) (2024)
Gerald R Galluppi, Malidi Ahamadi, Souvik Bhattacharya, Nageshwar Budha, Ferdous Gheyas, Chi-Chung Li, Yuan Chen, Anne-Gaëlle Dosne, Niels Rode Kristensen, Mindy Magee, Mahesh N Samtani, Vikram Sinha, Kunal S Taskar, Vijay V Upreti, Jianning Yang, Jack Cook
Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program. Clinical pharmacology and therapeutics (2024)
Tian Yu, Xiangyu Liu, Chi-Yuan Wu, Zhiyu Tang, Hongwei Wang, Patrick Schnell, Ya Wan, Kun Wang, Lucy Liu, Yuying Gao, Srikumar Sahasranaman, Nageshwar Budha
Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors. Clinical and translational science 17 (3) (2024)
Tian Yu, Xiangyu Liu, Chi-Yuan Wu, Zhiyu Tang, Hongwei Wang, Patrick Schnell, Ya Wan, Kun Wang, Lucy Liu, Yuying Gao, Srikumar Sahasranaman, Nageshwar Budha
Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors. Clinical and translational science 17 (3) (2024)